Supernus 製藥公司
US ˙ NasdaqGM ˙ US8684591089

SecuritySUPN / Supernus Pharmaceuticals, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership412,683 shares
Latest Disclosed Value $ 21,331,585
Invesco Ltd. reports 4.28% increase in ownership of SUPN / Supernus Pharmaceuticals, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 412,683 shares of Supernus Pharmaceuticals, Inc. (US:SUPN) valued at $21,331,584 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 395,761 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of 4.28% during the quarter. The current value of the position is $18,446,930 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 412,683 16,922 4.28 21,332 8.45 0.0033
2026-02-19 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 395,761 33,895 9.37 19,669 13.74 0.0030
2025-11-13 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 361,866 -37,153 -9.31 17,294 37.50 0.0027
2025-08-13 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 399,019 -131,612 -24.80 12,577 -27.63 0.0021
2025-05-12 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 530,631 22,562 4.44 17,378 -5.41 0.0033
2025-02-13 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 508,069 22,027 4.53 18,372 21.23 0.0034
2024-11-12 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 486,042 -102,661 -17.44 15,155 -3.77 0.0029
2024-08-13 2024-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 588,703 -15,071 -2.50 15,748 -23.54 0.0033
2024-05-14 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 603,774 73,826 13.93 20,595 34.29 0.0044
2024-02-13 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 529,948 -152,743 -22.37 15,337 -18.52 0.0036
2023-11-13 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 682,691 -64,791 -8.67 18,822 -16.24 0.0051
2023-08-11 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 747,482 67,669 9.95 22,469 -8.77 0.0059
2023-05-12 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 679,813 26,423 4.04 24,630 5.68 0.0069
2023-02-13 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 653,390 18,961 2.99 23,306 8.52 0.0068
2022-11-14 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 634,429 -47,887 -7.02 21,476 8.83 0.0069
2022-08-15 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 682,316 61,537 9.91 19,733 -1.65 0.0060
2022-05-16 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 620,779 -123,486 -16.59 20,064 -7.55 0.0051
2022-02-14 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 744,265 -287,515 -27.87 21,702 -21.14 0.0052
2021-11-15 2021-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,031,780 273,377 36.05 27,518 17.84 0.0070
2021-08-17 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 758,403 31,120 4.28 23,352 22.65 0.0057
2021-05-17 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 727,283 -73,055 -9.13 19,040 -5.45 0.0051
2021-02-16 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 800,338 64,970 8.84 20,137 31.40 0.0059
2020-11-16 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 735,368 35,255 5.04 15,325 -7.83 0.0052
2020-08-14 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 700,113 -115,278 -14.14 16,627 13.35 0.0059
2020-05-15 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 815,391 -220,544 -21.29 14,669 -40.30 0.0062
2020-02-14 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,035,935 690,310 199.73 24,572 158.71 0.0076
2019-11-14 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 345,625 -53,546 -13.41 9,498 -28.09 0.0025
2019-08-14 2019-06-30 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 399,171 -479,378 -54.56 13,209 -57.09 0.0034
2019-08-14 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 399,171 -877,499 13,209
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 878,549 -50,075 -5.39 30,785 -0.21 0.0104
2019-02-14 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 928,624 -693,471 -42.75 30,849 -62.23 0.0118
2018-11-14 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,622,095 132,126 8.87 81,673 -8.41 0.0257
2018-08-14 2018-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,489,969 -94,859 -5.99 89,174 22.85 0.0295
2018-05-15 2018-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,584,828 -304 -0.02 72,585 14.91 0.0271
2018-02-14 2017-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,585,132 -477,520 -23.15 63,169 -23.44 0.0228
2017-11-14 2017-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,062,652 -173,253 -7.75 82,507 -14.38 0.0305
2017-08-14 2017-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,235,905 576,311 34.73 96,368 85.52 0.0300
2017-05-15 2017-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,659,594 -279,899 -14.43 51,946 6.07 0.0171
2017-02-14 2016-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,939,493 43,565 2.30 48,973 4.45 0.0165
2016-11-14 2016-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,895,928 312,325 19.72 46,885 45.35 0.0161
2016-08-15 2016-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,583,603 375,258 31.06 32,257 75.05 0.0118
2016-05-16 2016-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,208,345 -409,905 -25.33 18,427 -15.27 0.0075
2016-02-16 2015-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,618,250 56,832 3.64 21,749 -0.73 0.0087
2015-11-16 2015-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,561,418 90,345 6.14 21,908 -12.29 0.0093
2015-08-14 2015-06-30 13F SUPERNUS PHARMACEUTICALS COMMON 868459108 1,471,073 1,471,073 24,979 0.0098
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.